订阅小程序
旧版功能

PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial.

Juan Pablo Alderuccio,Isildinha M Reis,Mehdi Hamadani,Muthiah Nachiappan, Salman Leslom,Brad S Kahl,Weiyun Z Ai,John Radford,Melhem Solh,Kirit M Ardeshna,Brian T Hess,Matthew A Lunning,Pier Luigi Zinzani,Anastasios Stathis,Carmelo Carlo-Stella,Izidore S Lossos,Paolo F Caimi,Sunwoo Han,Fei Yang,Russ A Kuker,Craig H Moskowitz

Clinical cancer research : an official journal of the American Association for Cancer Research（2024）

引用 3|浏览54
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要